Beste IDEA Pharma Podcasts (2025)

1
Bold Science, Bigger Bets: Mathai Mammen on Visionary R&D and Transforming Biopharma 50:20

17d ago50:20

50:20

In this insightful episode of IDEA Collider, Mike welcomes Mathai Mammen, Chairman and CEO of Parabilis Medicines. Mathai shares his extensive journey through academia, MD PhD program at Harvard, co-founding Theravance, and leadership roles at Merck and J&J. They delve into Mathai's innovative approach to creating transformative medicines, navigati…

1
Bridging Clinical Practice and Biotech: Paul Peter Tak's Transformative Journey 49:58

1M ago49:58

49:58

In this episode of Idea Collider, host Mike Rea interviews Paul Peter Tak, CEO of Candel Therapeutics, discussing his remarkable journey from a clinician in Amsterdam to leading cutting-edge biotech companies. Paul shares pivotal moments in his career, the challenges of transitioning from academia to big pharma, and the innovative principles he app…

1
Creating Breakthroughs in Oncology: A Conversation with Susan Galbraith of AstraZeneca 43:26

2M ago43:26

43:26

In this episode of Idea Collider, we sit down with Susan Galbraith from AstraZeneca, a leading figure in oncology R&D. Susan shares her journey from medical training in Manchester and Cambridge to spearheading transformative cancer treatments at AstraZeneca. She discusses pivotal moments in her career, AstraZeneca's vision for eliminating cancer as…

1
Biotech Innovations & Leadership with John Maraganore 39:02

2M ago39:02

39:02

In this episode of IDEA Collider, we dive into the world of biotech innovation with John Maraganore, former CEO of Alnylam Pharmaceuticals. Recognized as a trailblazer, John transformed RNA interference from a scientific concept into a revolutionary class of medicines, leading the development of five life-changing drugs. Join us as we explore John'…

1
IDEA Collider- with IDEA Pharma COO Jacqueline Barendregt and Exploristics Founder & CEO Aiden Flynn 18:33

1y ago18:33

18:33

We are excited to tell you more about the IDEA Pharma and Exploristics partnership. IDEA’s COO, Jacqui Barendregt, asked Exploristics Founder and CEO Aiden Flynn five key questions about the innovative service model and, most importantly, the value to the pharmaceutical industry this newly formed partnership will bring.…

1
Embracing Innovation and Collaboration in the Pharma Industry with Dr. Nedim Pipic 39:16

2y ago39:16

39:16

Welcome to another episode of Idea Collider with your host, Mike Rea. In this engaging conversation, we delve into the world of pharmaceutical innovation and collaboration. Our guest, Dr. Nedim Pipic, a pharmaceutical expert specializing in mental and retinal health, shares his journey and passion for making a difference. Join us as we explore the …

1
Exploring the book “Quit: The Power of Knowing When to Walk Away” by Annie Duke 1:21:49

2+ y ago1:21:49

1:21:49

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today, Annie Duke joins us on the show to discuss her latest book, “Quit: The Power of Knowing When to Walk Away.” Annie is an Author, Professional Speaker, Decision Strategist & co-founder of The Alliance for Decision Education, a non-profit…

1
The Industrial Revolution of Drug Discovery with Dr. Michael Secora 51:36

2+ y ago51:36

51:36

Welcome to another incredible episode of the IDEA Collider series with your host Mike Rea. Today the Chief Financial Officer at Recursion, Dr. Michael Secora, joins us on the show as we discuss the industrial revolution of drug discovery. Michael is a scientist and a former equity investor. In the episode, Michael delves into the reasons behind the…

1
Embracing Digital Technology for Better Healthcare with Mary Lou Jepsen 49:48

2+ y ago49:48

49:48

The healthcare industry is moving towards a digital revolution. With the help of digital technology, healthcare providers can now provide better and more efficient services to their patients. Digital technology has also proven to have a positive impact on patient outcomes, as well as the cost of care. Companies such as Openwater, which focuses on c…

1
Competitive Advantage & Positioning with Jaynie Smith 42:40

2+ y ago42:40

42:40

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today a competitive advantage expert, and CEO of Smart Advantage, Jaynie Smith, joins us on the show. She delves into snippets in her book, Creating Competitive Advantage, & the role of competitive advantage in increasing sales and protecting…

1
Exploring Compounding Pharmacy with Sherine Khalil 53:21

2+ y ago53:21

53:21

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by Sherine Khalil, the Vice President and Chief Business Officer for Valor Compounding Pharmacy. She talks about sterile and non-sterile compounding as well as her transition from the nonprofit world to academic medicine. …

1
Pricing, Value, and Innovation with Prof. Brian D Smith 50:07

2+ y ago50:07

50:07

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by Prof. Brian D Smith, a pharma innovation geek for the past 24 years. He talks about his latest book, “ New Drugs, Fair Prices,” and how to manage the pharmaceutical innovation ecosystem for sustainable and affordable ne…

1
Marketing Intelligence & Data Quality with Matthew Wahlrab 57:39

2+ y ago57:39

57:39

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today a tech pioneer, founder & CEO of Rapid Alpha joins us on the show as we discuss marketing intelligence & why business leaders can not ignore data quality. Matthew talks about his career path from intellectual property to where he is now…

1
Developing Effective Leadership, Strong Organizational Culture & Behavior with Tim Kight 57:07

2+ y ago57:07

57:07

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today, Tim Kight, a long-life student of elite performance, coach, and Focus 3 CEO joins us on the show as we discuss developing leaders & strengthening organizational culture to achieve better results. Tim delves into the five drivers of org…

1
Asymmetric Learning and Its Impact On Culture with John Waid 47:40

2+ y ago47:40

47:40

Welcome to another amazing episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. In today’s episode, Mike is joined by John Waid. John is a thought leader, author, and CEO of a unique boutique global culture & leadership development firm. He talks about culture and the purpose of an organization. Additionally, he talks about…

1
Creativity & Innovation In Corporate Venture With Rita McGrath 59:49

3y ago59:49

59:49

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by a consultant, best-selling author, and one of the world’s top experts on strategy and innovation, Rita McGrath. In the episode, Rita talks to us about her transition from a political science career to innovation in the …

1
Using AI In Drug Discovery With Andrew Hopkins 50:34

3y ago50:34

50:34

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by Andrew Hopkins, the Founder & CEO of Exscientia, as he talks to us about the use of AI in drug discovery. In the episode, we delve into Andrew’s journey of developing better drug discovery methods, applying data mining …

1
The Misconceptions In The Pharma Industry With John L. Lamattina 1:02:56

3y ago1:02:56

1:02:56

In this incredible episode, Mike Rea is joined by Dr. John L. LaMattina. John is the former Senior Vice President of Pfizer Inc and President of Pfizer Global Research & Development. Additionally, he is a senior partner at PureTech Health and an author. He talks about the misconception about Pfizer’s profiteering from the pandemic and the drug pric…

1
Asymmetric Learning in Cybersecurity & Intelligence with Gene Yoo 47:23

3y ago47:23

47:23

Welcome to another fantastic episode of the IDEA Collider│Asymmetric learning series with your host Mike Rea. Today we are joined by Gene Yoo, the Chief Executive Officer at Resecurity, Inc. He talks about asymmetric learning in cybersecurity & Intelligence and what gives Resecurity an edge over other competitors in the market Moreover, he shares a…

1
Where Do Good Ideas Come from? With Steven Johnson 58:33

3y ago58:33

58:33

Welcome to another fantastic episode of the IDEA Collider│Asymmetric learning series with your host Mike Rea. In today’s episode, Mike interviews Steven Johnson, an author of 13 books, a TV host, and a podcaster. He talks about Innovation vs. Invention and explains where good ideas come from. Additionally, Steven talks about the Individual and orga…

1
Welcome Back to Series II of IDEA Collider 0:47

3y ago0:47

0:47

Von Mike Rea

1
Sick Money: The Truth About The Global Pharmaceutical Industry With Billy Kenber 58:06

3y ago58:06

58:06

Welcome to another fantastic episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by Billy Kenber, an investigative journalist at “The Times.” He talks about his journey to writing his book ‘Sick Money’ and the content in the book. Additionally, he talks about the pharmaceutical industry’s social contrac…

1
IDEA Collider | Kabir Nath 52:11

4y ago52:11

52:11

Kabir Nath is President & CEO, Otsuka North America Pharmaceutical Business Throughout his career, Kabir has built bridges between cultures. His work has taken him across the globe, spanning 3 continents and multiple countries. Kabir has lived and worked in the United Kingdom, France, Spain, India, Singapore, China, and the United States. He has co…

1
IDEA Collider | Pharma Book Club | Kat Arney 47:42

4y ago47:42

47:42

(Now also released in paperback: https://amzn.to/3lWjo2B) Kat can be found at First Create The Media: and on Twitter: @Kat_Arney Find out more about Rebel Cell here: https://www.rebelcellbook.com/about-rebel-cell-cancer-book Many of us think of cancer as a contemporary killer, a disease of our own making caused by our modern lifestyles. But, as Kat…

1
IDEA Collider | Susanne Schaffert, PhD 51:22

4y ago51:22

51:22

As President of Novartis Oncology, Susanne Schaffert is pursuing a bold strategy to reimagine the research, development and commercialization of innovative treatments that will help improve and extend the lives of people with cancer and related blood disorders. Susanne has held positions of increasing seniority across a range of business areas duri…

1
IDEA Collider | Dan Skovronsky 49:02

4y ago49:02

49:02

Dan Skovronsky is the chief scientific officer of Eli Lilly and Company. He serves as senior vice president of science and technology and president of Lilly Research Laboratories. He also has responsibility for global business development. Dan joined Lilly in 2010 when the company acquired Avid Radiopharmaceuticals Inc., where he had been CEO since…

1
IDEA Collider | Pharma Book Club | Brian Christian 50:06

4+ y ago50:06

50:06

With so much at stake in the application of AI/ Machine Learning to pharma, biotech and medicine, this wonderful book touches on biases, systems of learning, and the choices we have to make to properly harness the power of what is possible. Email mike at ideapharma.com to enter a lottery to win a copy of the hardcover book, closing date 26th Februa…

1
IDEA Collider | Nick Wood, Benji Compston 42:15

4+ y ago42:15

42:15

Syn is an award winning music agency and creative solutio, providing music strategy, composition, sound design and sonic branding for advertising, cinema and television, as well as music supervision, licensing and music curation services and our studios record voiceover, ADR and narration. In this interview, we discuss the user experience (patient,…

1
IDEA Collider | Riccardo Zacconi 42:39

4+ y ago42:39

42:39

Great interview with Riccardo on CNBC Find out more about PTEN Research at https://www.ptenresearch.orgVon Mike Rea, Riccardo Zacconi

1
IDEA Collider | John Tsai, MD 45:20

4+ y ago45:20

45:20

Covering a wide variety of topics, with a special focus on Novartis as one of the best examples of a learning organisation in pharma. On cultures of innovation, 'unbossing', decision making and measuring what matters John can be found on LinkedIn: https://www.linkedin.com/in/john-tsai-md-ab398b4/ or contacted by email at john_tsai.office at novarti…

1
IDEA Collider | Andy Coravos and Jen Goldsack, The DiMe Society Playbook 45:27

4+ y ago45:27

45:27

A discussion of The Playbook, from DiMe Society, Digital Clinical Measures Introducing the essential industry guide for successfully developing & deploying digital clinical measures across clinical research, clinical care, and public health https://playbook.dimesociety.org More on Andy (Andrea) Coravos here: http://www.andreacoravos.com More on Jen…

1
IDEA Collider | Carinne Brouillon, Edward Hæggström, Rob Scott | Pharma Innovation Summit 46:48

4+ y ago46:48

46:48

Carinne Brouillon is a Member of the Board of Managing Directors, with responsibility for the Human Pharma Business Unit Professional milestones 2018 – 2019 Global Head of Therapeutic Areas, Boehringer Ingelheim 2014 – 2018 Head of Global Commercial Strategy Neuroscience at Janssen, Johnson & Johnson’s Pharmaceutical Company 2012 – 2018 President o…

1
IDEA Collider | Defining and Measuring Innovation 32:09

4+ y ago32:09

32:09

This episode replays some of a round table we held at JP Morgan, back when people used to travel... It features the voices of Mike Rea, in conversation with Linda Avey, Co-founder of 23andMe, and Curious, Inc, Amrit Chaudhuri, CEO, Mass Innovation Labs (now SmartLabs), Steve Holtzman, then CEO, Decibel Therapeutics, Raj Kannan then SVP, Global Fran…

1
IDEA Collider | Pharma Book Club | Lee Vinsel and Andrew L. Russell 46:01

5y ago46:01

46:01

ABOUT THE INNOVATION DELUSION Innovation is the hottest buzzword in business. But what if our obsession with finding the next big thing has distracted us from the work that matters most? “The most important book I’ve read in a long time . . . It explains so much about what is wrong with our technology, our economy, and the world, and gives a simple…

1
IDEA Collider | Dr Peter Bach 59:00

5y ago59:00

59:00

Peter B. Bach is a physician, epidemiologist, researcher, and respected healthcare policy expert whose work focuses on the cost and value of anticancer drugs. Dr. Bach is leading efforts to increase understanding of the US drug development process and develop new models for drug pricing that include value to patients Dr. Bach described a 100-fold i…

1
IDEA Collider | Jen Horonjeff 46:26

5y ago46:26

46:26

In conversation, discussing patient input into clinical programs, unmet need assessments, measurement and so much more. Jen was diagnosed with juvenile arthritis as an infant and now has a laundry list of other conditions and surprises (like a brain tumor). She is passionate about elevating and valuing the patient voice, and went on to become a hea…

1
IDEA Collider | Pharma Book Club | Gerald Posner 57:55

5y ago57:55

57:55

From the Amazon description: Pharmaceutical breakthroughs such as antibiotics and vaccines rank among some of the greatest advancements in human history. Yet exorbitant prices for life-saving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on prescription opioids have caused many to lose …

1
IDEA Collider | Daphne Zohar 45:52

5y ago45:52

45:52

PureTech Health is an advanced, clinical-stage biopharmaceutical company developing novel medicines targeting serious diseases that result from dysfunctions in the nervous, immune, and gastrointestinal systems (brain-immune-gut or the “BIG” axis), which together represent the adaptive human systems. PureTech Health is at the forefront of understand…

1
IDEA Collider | Pharma Book Club | Jane Metcalfe 40:24

5y ago40:24

40:24

25 Visions for the Future of Our Species We now have the tools to transform ourselves and our species. Greater health and longevity, enhanced brains, and engineered fertility are in the works. What’s just over the horizon is even more astonishing. We call this the neobiological frontier. The book is a collection of 25 essays, interviews, and works …

1
IDEA Collider | Pharma Book Club | Thomas Hager 57:40

5y ago57:40

57:40

Chapter-by-chapter discussion, covering: opium/ heroin antibiotics contraceptive pill vaccines and more... Find more by Thomas Hager here: https://www.thomashager.netVon Thomas Hager, Mike Rea

1
IDEA Collider | Pharma Book Club | Dr Jeremy Levin 43:51

5y ago43:51

43:51

Dr. Jeremy M. Levin is Chairman and CEO of Ovid Therapeutics Inc (NASDAQ:OVID), a company whose mission is to bring treatment to patients with rare neurological conditions. Dr. Levin is concurrently the chairman of the Biotechnology Innovation Organization (BIO). Prior to founding Ovid, Dr. Levin was president and CEO of Teva Pharmaceutical Industr…

1
IDEA Collider | Pharma Book Club | Annie Duke 1:11:49

5y ago1:11:49

1:11:49

The books Annie recommends: Maria Konnikova The Biggest Bluff: How I Learned to Pay Attention, Master Myself, and Win Philip Tetlock, Dan Gardner Superforecasting: The Art and Science of Prediction Don A Moore Perfectly Confident: How to Calibrate Your Decisions WiselyVon Mike Rea, Annie Duke

1
IDEA Collider | Pharma Book Club | Peter Kolchinsky 55:37

5y ago55:37

55:37

Peter on Twitter: https://twitter.com/peterkolchinsky The book's website: https://peterkolchinsky.com/bio Link to the Katherine Eban discussion:Von Peter Kolchinsky, mike rea

1
IDEA Collider | Deborah Waterhouse 48:33

5y ago48:33

48:33

Deborah Waterhouse, CEO ViiV HealthcareDeborah was appointed to GSK’s Corporate Executive Team on 8th January 2020. She became Chief Executive Officer of ViiV Healthcare on 1st April 2017. ViiV Healthcare is majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders.In this interview, we discuss cultures of innovation, innovation …

1
IDEA Collider | Melinda Richter 50:06

5y ago50:06

50:06

For more on JLABS, go to https://jlabs.jnjinnovation.com/JLABSNavigator#/ As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a …

1
IDEA Collider | Pharma Book Club | Clifton Leaf 49:43

5y ago49:43

49:43

In an archive recording, from 2015, the author of one of the best pharma-related books of the past decade, Clifton Leaf, gives us an insight into The Truth In Small Doses, Why We're Losing the War on Cancer-and How to Win It. (In this case, archive means that we thought we had lost the file, and then found it in a place we didn't expect!)Clifton, n…

1
IDEA Collider | Jack Scannell 57:57

5+ y ago57:57

57:57

Links to the papers we discuss Diagnosing the Decline of Pharmaceutical R&D efficiency (2012): https://www.nature.com/articles/nrd3681 When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis (2016): https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147215 Pharmaceutical Evolution: Clinical Selec…

1
IDEA Collider | Pharma Book Club | Matt Ridley 31:37

5+ y ago31:37

31:37

Discussion of the new Matt Ridley book, How Innovation Works, published in May 2020. http://www.mattridley.co.uk Matt Ridley's books have sold over a million copies, been translated into 31 languages and won several awards. His books include The Red Queen, The Origins of Virtue, Genome, Nature via Nurture, Francis Crick, The Rational Optimist and T…

1
IDEA Collider | In conversation with Amrit Chaudhuri 51:39

5+ y ago51:39

51:39

Why Boston/ Cambridge and South San Francisco? Why not New York? Cultures of innovation The new way, scaling start-ups Critical factors for biotech hubs Europe/ The UK and the rest of the world Where does innovation come from? How is it defined?Von Amrit Chaudhuri, Mike Rea

1
IDEA Collider | Vinayak K Prasad | Pharma Book Club 56:07

5+ y ago56:07

56:07

Interview with Vinayak K. Prasad, author of Malignant: How Bad Policy and Bad Evidence Harm People with CancerAn essential listen for anyone involved in cancer R&D. Vinay is one of the more interesting voices on Twitter (@VPrasadMDMPH), and the book presents a wonderful exploration of what's right with oncology R&D and what's wrong. The interview r…

Podcasts, die es wert sind, gehört zu werden

IDEA Pharma Podcasts

Podcasts, die es wert sind, gehört zu werden

Kurzanleitung